United States · FDA National Drug Code directory

Losartan Potassium and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63187-918_038d5ca0-71f9-4135-9921-2e1889a9cf23
Product NDC
63187-918
Form
TABLET, FILM COATED
Composition / generic term
Losartan Potassium and Hydrochlorothiazide
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20160523
Source listing expiry
20261231

Source-listed ingredients

  • LOSARTAN POTASSIUM — 100 mg/1
  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (63187-918-30) · 63187-918-30
  • 60 TABLET, FILM COATED in 1 BOTTLE (63187-918-60) · 63187-918-60
  • 90 TABLET, FILM COATED in 1 BOTTLE (63187-918-90) · 63187-918-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Losartan Potassium and Hydrochlorothiazide — United States | Molindra Medicines